Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05601973
Title AMAZE-lung: Amivantamab, Lazertinib and Bevacizumab in Patients With EGFR-mutant Advanced Non-small Cell Lung Cancer With Progression on Previous Third-generation EGFR-TKI (AMAZE-lung)
Acronym AMAZE-lung
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors ETOP IBCSG Partners Foundation
Age Groups: senior | adult
Covered Countries NLD | ITA | GBR | FRA | ESP

No variant requirements are available.